Share-based Payment Arrangement, Expense of Bionano Genomics, Inc. from 30 Sep 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bionano Genomics, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2017 to 30 Sep 2025.
  • Bionano Genomics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $941,000, a 57% decline year-over-year.
  • Bionano Genomics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $5,544,000, a 50% decline year-over-year.
  • Bionano Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $9,736,000, a 36% decline from 2023.
  • Bionano Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $15,178,000, a 32% decline from 2022.
  • Bionano Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $22,417,000, a 131% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Bionano Genomics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,544,000 $941,000 -$1,261,000 -57% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $6,805,000 $1,080,000 -$1,503,000 -58% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $8,308,000 $1,587,000 -$1,428,000 -47% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $9,736,000 $1,936,000 -$1,436,000 -43% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $11,172,000 $2,202,000 -$1,790,000 -45% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $12,962,000 $2,583,000 -$1,349,000 -34% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $14,311,000 $3,015,000 -$867,000 -22% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 $15,178,000 $3,372,000 -$2,107,000 -38% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $17,285,000 $3,992,000 -$2,067,000 -34% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $19,352,000 $3,932,000 -$1,845,000 -32% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q2
Q1 2023 $21,197,000 $3,882,000 -$1,220,000 -24% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $22,417,000 $5,479,000 +$677,000 +14% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $21,740,000 $6,059,000 +$3,271,000 +117% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $18,469,000 $5,777,000 +$4,019,000 +229% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $14,450,000 $5,102,000 +$4,731,000 +1275% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $9,719,000 $4,802,000 +$4,351,000 +965% 01 Oct 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $5,368,000 $2,788,000 +$2,341,000 +524% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $3,027,000 $1,758,000 +$1,430,000 +436% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $1,597,000 $371,000 +$43,000 +13% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $1,554,000 $451,000 +$93,977 +26% 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $1,460,023 $447,000 +$83,000 +23% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $1,377,023 $328,000 -$8,000 -2.4% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021 2021 Q2
Q1 2020 $1,385,023 $328,000 +$39,000 +13% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $1,346,023 $357,023 +$302,579 +556% 01 Oct 2019 31 Dec 2019 10-K 23 Mar 2021 2020 FY
Q3 2019 $1,043,444 $364,000 +$310,875 +585% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2020 Q3
Q2 2019 $732,569 $336,000 +$283,019 +534% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $449,550 $289,000 01 Jan 2019 31 Mar 2019 10-Q 18 Jun 2020 2020 Q1
Q4 2018 $54,444 01 Oct 2018 31 Dec 2018 10-Q 09 May 2019 2019 Q1
Q3 2018 $53,125 +$29,000 +120% 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $52,981 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q3 2017 $24,125 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2018 Q3

Bionano Genomics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $9,736,000 -$5,442,000 -36% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $15,178,000 -$7,239,000 -32% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $22,417,000 +$12,698,000 +131% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024 2023 FY
2021 $9,719,000 +$8,165,000 +525% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2020 $1,554,000 +$207,977 +15% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
2019 $1,346,023 +$152,150 +13% 01 Jan 2019 31 Dec 2019 10-K 23 Mar 2021 2020 FY
2018 $1,193,873 +$811,043 +212% 01 Jan 2018 31 Dec 2018 10-K 10 Mar 2020 2019 FY
2017 $382,830 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.